ProQR Therapeutics (PRQR) EBITDA (2013 - 2026)
ProQR Therapeutics (PRQR) posted EBITDA of -$9.43 million for the quarter ended Jun 30, 2026, compared with -$13.1 million a year earlier.
Powered by 
Analysis
ProQR Therapeutics (PRQR) EBITDA (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at ProQR Therapeutics was -$46.81 million; for the year ended Dec 31, 2025, it was -$46.03 million.
- In prior years, ProQR Therapeutics' EBITDA was -$29.99 million in the year ended Dec 31, 2024, -$31.74 million in the year ended Dec 31, 2023, -$66.02 million in the year ended Dec 31, 2022 and -$64.95 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly EBITDA since the quarter ended Sep 30, 2024.
- According to Business Quant data, EBITDA for the three prior quarters was -$15.17 million (quarter ended Mar 31, 2026), -$9.8 million (quarter ended Dec 31, 2025) and -$12.41 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 5.89 Bn |
| 10 | ProQR Therapeutics | 145.89 Mn | -314.77 Mn | - | -9.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.43 Mn |
| Mar 31, 2026 | -15.17 Mn |
| Dec 31, 2025 | -9.80 Mn |
| Sep 30, 2025 | -12.41 Mn |
| Jun 30, 2025 | -13.10 Mn |
| Mar 31, 2025 | -10.66 Mn |
| Dec 31, 2024 | -10.06 Mn |
| Sep 30, 2024 | -8.82 Mn |
| Jun 30, 2024 | -3.11 Mn |
| Mar 31, 2024 | -8.02 Mn |
| Dec 31, 2023 | -5.96 Mn |
| Sep 30, 2023 | -7.35 Mn |
| Jun 30, 2023 | -8.95 Mn |
| Mar 31, 2023 | -9.49 Mn |
| Dec 31, 2022 | -11.95 Mn |
| Sep 30, 2022 | -19.37 Mn |
| Jun 30, 2022 | -16.26 Mn |
| Mar 31, 2022 | -18.49 Mn |
| Dec 31, 2021 | -19.19 Mn |
| Sep 30, 2021 | -16.53 Mn |
API Access
ProQR Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();